PIERIMARCHI, PASQUALE
 Distribuzione geografica
Continente #
AS - Asia 2.159
NA - Nord America 1.666
EU - Europa 696
SA - Sud America 465
Continente sconosciuto - Info sul continente non disponibili 166
AF - Africa 50
OC - Oceania 4
Totale 5.206
Nazione #
US - Stati Uniti d'America 1.574
SG - Singapore 893
CN - Cina 440
BR - Brasile 362
IT - Italia 295
VN - Vietnam 248
HK - Hong Kong 246
FR - Francia 135
NL - Olanda 95
JP - Giappone 60
KR - Corea 59
BD - Bangladesh 52
CA - Canada 44
IN - India 44
GB - Regno Unito 33
DE - Germania 32
CO - Colombia 29
AR - Argentina 26
ID - Indonesia 24
FI - Finlandia 19
EC - Ecuador 16
PL - Polonia 16
ZA - Sudafrica 15
MX - Messico 14
ES - Italia 13
IL - Israele 13
IQ - Iraq 11
TR - Turchia 11
UA - Ucraina 11
CL - Cile 10
MA - Marocco 9
MY - Malesia 9
VE - Venezuela 9
PY - Paraguay 8
SA - Arabia Saudita 8
PH - Filippine 6
AT - Austria 5
DO - Repubblica Dominicana 5
HN - Honduras 5
LT - Lituania 5
RU - Federazione Russa 5
SE - Svezia 5
TT - Trinidad e Tobago 5
UZ - Uzbekistan 5
KE - Kenya 4
SC - Seychelles 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EE - Estonia 3
EG - Egitto 3
HR - Croazia 3
HU - Ungheria 3
IE - Irlanda 3
JM - Giamaica 3
NI - Nicaragua 3
NP - Nepal 3
PK - Pakistan 3
PT - Portogallo 3
TH - Thailandia 3
AO - Angola 2
AU - Australia 2
BS - Bahamas 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MT - Malta 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SV - El Salvador 2
TJ - Tagikistan 2
TN - Tunisia 2
AG - Antigua e Barbuda 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
GR - Grecia 1
GT - Guatemala 1
JO - Giordania 1
KH - Cambogia 1
KY - Cayman, isole 1
LB - Libano 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PF - Polinesia Francese 1
PR - Porto Rico 1
RS - Serbia 1
RW - Ruanda 1
Totale 5.034
Città #
Santa Clara 551
Singapore 489
Hong Kong 239
Hefei 140
Rome 136
San Jose 129
Beijing 113
Ashburn 109
Lauterbourg 98
Ho Chi Minh City 89
Seoul 59
Hanoi 53
Los Angeles 49
Tokyo 45
São Paulo 34
Guangzhou 30
New York 26
Buffalo 21
Atlanta 17
Council Bluffs 16
Frankfurt am Main 16
Brooklyn 15
Orem 15
Brasília 14
Dallas 14
Milan 14
Helsinki 13
London 13
Warsaw 13
Aversa 12
Da Nang 12
Rio de Janeiro 12
Bogotá 10
Miami 10
Phoenix 10
Chicago 9
Houston 9
Montreal 9
Philadelphia 9
Bengaluru 8
Can Tho 8
Denver 8
Düsseldorf 8
Minamishinagawa 8
Quito 8
Toronto 8
Belo Horizonte 7
Haiphong 7
Johannesburg 7
Biên Hòa 6
Hải Dương 6
Istanbul 6
Kuala Lumpur 6
Mexico City 6
Newark 6
Shanghai 6
Thái Bình 6
Tây Ninh 6
Baghdad 5
Buenos Aires 5
Campinas 5
Cape Town 5
Charlotte 5
Dhaka 5
Florence 5
Jacksonville 5
Jeddah 5
Lappeenranta 5
Naples 5
Rochester 5
Salvador 5
Stockholm 5
Tashkent 5
Tel Aviv 5
The Bronx 5
Boardman 4
Caracas 4
Chennai 4
Fortaleza 4
Maceió 4
Manchester 4
Montevideo 4
Mumbai 4
New Delhi 4
Orlando 4
Osaka 4
Pescara 4
Portsmouth 4
San Francisco 4
Seattle 4
Tampa 4
Washington 4
Amsterdam 3
Anápolis 3
Asunción 3
Bandung 3
Bari 3
Boston 3
Campos dos Goytacazes 3
Caxias do Sul 3
Totale 2.980
Nome #
Targeting the heat schock factor 1 by RNA interference: A potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer 105
Bioassay-guided Isolation of Nigracin, responsible for the Tissue Repair properties of Drypetes klainei Stem Bark. 100
Preclinical Validation of SilkBridge(TM)for Peripheral Nerve Regeneration 82
Nature-derived compounds modulating Wnt/beta-catenin pathway: a preventive and therapeutic opportunity in neoplastic diseases 79
Essential Oil from Eucalyptus globulus (Labill.) Activates Complement Receptor-Mediated Phagocytosis and Stimulates Podosome Formation in Human Monocyte-Derived Macrophages 77
Atrial Natriuretic Peptide Acts As a Neuroprotective Agent in In Vitro Models of Parkinson's Disease via Up-Regulation of the Wnt/ß-Catenin Pathway 76
Therapeutic use of new pharmaceutical preparation containing antitumoral drugs bound to hyaluronic acid in the treatment of neoplasias 75
Plasmid vector design and technologies for DNA vaccine development 70
RAPPORTO TECNICO IFT-CNR Requisiti tecnici e regolatori per lo sviluppo sperimentale di prodotti combinati farmaco/dispositivo per il trattamento del carcinoma della vescica Autori: Manuela Zonfrillo1, Pasquale Pierimarchi1, Martina Rescigno 69
A putative role for NGF- and p75-like immunoreactive proteins in earthworm defence mechanisms 68
Anti-proliferative effect of atrial natriuretic peptide on colorectal cancer cells: Evidence for an Akt-mediated cross-talk between NHE-1 activity and Wnt/beta-catenin signaling. 67
Association of OPG-RANKL ratio with left ventricular hypertrophy and geometric remodeling in male overweight/obese youths 66
Nonalcoholic Fatty Liver Disease Is Associated With Low Skeletal Muscle Mass in Overweight/Obese Youths 66
The Iterative Development of Medicines Through the European Medicine Agency's Adaptive Pathway Approach 65
New Perspective in HCV Clinical and Economical Management of the Current and Future Therapies 64
Phospho-TCTP as a therapeutic target of dihydroartemisinin for aggressive breast cancer cells 64
"Uso terapeutico di nuove preparazioni farmaceutiche contenenti farmaci antitumorali legati all'acido ialuronico nel trattamento delle neoplasie" 63
Thymosin alfa1 Activates Complement Receptor-Mediated Phagocytosis in Human Monocyte-Derived Macrophages 63
Carotid Extra-Media Thickness in Children: Relationships With Cardiometabolic Risk Factors and Endothelial Function 63
"Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to Hyaluronic acid in the treatment of neoplasia" 60
Nerve Growth Factor (NGF) involvement in liver cirrhosis and hepatocellular carcinoma. 60
PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment 59
Phospho-TCTP as a therapeutic target of dihydroartemisinin for aggressive breast cancer cells 59
In vitro evaluation of the wound healing activity of Drypetes klainei stem bark extracts 58
Multi-approach LC-MS methods for the characterization of species-specific attributes of monoclonal antibodies from plants 58
Suspected adverse drug reactions (ADRs) trends in older Italian patients: an analysis from the National Pharmacovigilance Network 58
Thymosin alfa1 modifies podosome architecture and promptly stimulates the expression of podosomal markers in mature macrophage 58
Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear... 58
EGFR and NOTCH1 signaling inhibition differently regulate cell growth and apoptosis of core and peritumoral glioblastoma stem-like cells 56
Synergistic antiproliferative and differentiating effect of 2,4-monofurfurylidene-tetra-O-methylsorbitol and 4,6-dimethyl-2-(3,4,5-trimethoxyphenylamino)pyrimidine on primary and immortalized keratinocytes 56
WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in Inflammatory Bowel Disease and sporadic colorectal cancer 56
Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases 55
Association between vitamin D levels and nonalcoholic fatty liver disease: potential confounding variables. 55
TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death. 55
SilkBridge: a novel biomimetic and biocompatible silk-based nerve conduit 54
Regulatory framework on bioequivalence criteria for locally acting gastrointestinal drugs: the case for oral modified release mesalamine formulations. 53
Rapid Chagas diagnosis in clinical settings using a multiparametric assay. 52
Pharmacological inhibition of Notch1 and EGFR signaling differently affect cell growth and survival of core and peritumoral glioblastoma-derived stem cells 51
Farmaci biosimilari da biotecnologie vegetali - Studio e sviluppo sperimentale di piattaforme vegetali per la realizzazione di innovative suite tecnologiche per la produzione di anticorpi monoclonali 50
The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation 49
Atrial Natriuretic peptide inhibits colorectal cancer cell growth by reverting the WNT/beta catenin pathway 48
Three-Layered Silk Fibroin Tubular Scaffold for the Repair and Regeneration of Small Caliber Blood Vessels: From Design to in vivo Pilot Tests 47
DNA Vaccine Strategy against chronic B-cell lymphoma: anti-idiotypic CDR3 vaccination. 47
Appropriatezza prescrittiva e pazienti anziani: serve un cambio di rotta? About Pharma and Medical Device; Luglio 2016. 47
Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model 46
DNA vaccines for B-cell lymphomas: Towards personalised medicine and tailored drugs 45
PREVENTIVE PEPTIDE VACCINE FOR COLORECTAL CANCER METASTASES. 44
A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cells. 44
Rapporto Tecnico congiunto AIFA e IFT-CNR WP 3.12 "Aspetti regolatori dell'uso dei farmaci negli anziani" nell'ambito del Progetto Invecchiamento. 44
DNA vaccination in B-cell lymphoma 44
CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis. 44
Nonionizing Radiation as a Noninvasive Strategy in Regenerative Medicine: The Effect of Ca(2+)-ICR on Mouse Skeletal Muscle Cell Growth and Differentiation. 43
Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B. 43
Genetic immunization with CDR3-based fusion vaccine confers protection and long-term tumor-free survival in a mouse model of lymphoma. 43
A putative role for NGF- and p75-like immunoreactive proteins in earthworm defence mechanisms. 43
DNA Vaccine Strategy against chronic B-cell lymphoma: anti-idiotypic CDR3 vaccination 42
Hovenia dulcis Thumberg: Phytochemistry, Pharmacology, Toxicology and Regulatory Framework for Its Use in the European Union 42
Nerve Growth Factor (NGF): a possible marker for hepatocellular carcinoma (HCC)? 40
Anti-Idiotypic CDR3 Vaccination Against Chronic B-Cell Lymphoma: Critical Components Of DNA Vaccines Against A Tumor Antigen 40
Rapporto Tecnico DOL.IMMU.CHEM (Bando 2011 l.r. 37, art.4) "nuove entità chimiche per la terapia del dolore, per il trattamento di patologie del sistema immunitario o per la chemioterapia" 40
Comparative cellular signal pathway analysis of metastatic colorectal cancer in human and preclinical animal model 40
Assesment of antipsoriatic activity of new molecules (A and B) in in-vitro models of adult human Keratinocytes 39
DNA vaccines for B-cell lymphomas: towards personalised medicine and tailored drugs 39
Up-regulation of melanocytic differentiation antigens induced by Cyanidin-3-O-beta-Glucopyranoside in human melanoma cells. 38
Epidemiological study on allergy and asthma phenotypes: subclinical and severe asthma. 38
Activation of Human Endogenous Retrovirus-K and production of infectious viral-like particles in human melanoma cells 38
Differentiation therapy: in vitro evidence making cyanidin-3-o-beta useful for prevention and treatment of melanoma 38
Thymosin Alpha-1 as a stimulatory agent of innate cell-mediated immune response 38
Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C. 37
New Molecular Biomarkers Candidates for the Development of Multiparametric Platforms for Hepatocellular carcinoma Diagnosis, Prognosis and Personalised Therapy 37
Evidence of electro-chemical interactions between multi-walled carbon nanotubes and human macrophages. 37
Nanosized cancer polymarker biochip - Laboratorio per la progettazione, produzione e validazione di biosensori optoe chemo-elettronici dedicati al rilevamento simultaneo di biomarkers associati a patologie tumorali 36
SciClone Pharmaceuticals Inc Further Investigations of Thymosin Alpha 1 Infused in Mice and Rats 36
Effetto stimolatorio dell olio essenziale di Eucalipto sull immunità innata cellulare 36
Identification of a new possibile molecular target for lung cancer: CSH-275 nonapeptide epitope 35
Nonionizing Radiation as a Noninvasive Strategy in Regenerative Medicine: The Effect of Ca(2+)-ICR on Mouse Skeletal Muscle Cell Growth and Differentiation. 35
Evaluation of effect of Eucaliptus essential oil on macrophage phagocytic activity by confocal laser scanning microscopy and cytofluorimetric analysis. 34
Electro-chemically mediated effects of MWNTs on human cells 34
THYMOSIN a1 IN COMBINATION WITH CYTOKINES AND CHEMOTHERAPY FOR THE TREATMENT OF CANCER. 34
Thymosin alfa up-regulates tumor antigen expression in colorectal cancer cells 33
In vivo up-regulation of the molecular target in a pre-clinical model metastatic colorectal cancer vaccine. AACR-NCI-EORTC 33
Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin-2 after intraperitoneal 5-fluorouracil delivery. 33
CD-44 Targeted therapy as an innovative strategy for anticancer drug delivery 33
Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma 33
DNA vaccine strategy against chronic B-cell lymphoma: anti-idiotypic CDR3 vaccination 32
Pivotal Role of PDGFR alpha in anti-Notch1 and EGFR Resistant Cancer Stem Cells Derived from Peritumor Tissue of Glioblastoma Multiforme. 32
Stimulatory effect of Eucalyptus essential oil on innate cell-mediated immune response. 32
Identification of a new possible molecolar target for lung cancer: CSH-275 nonpeptide epitope. 32
Differentiation of human melanoma cells induced by cyanidin-3-O-beta-glucopyranoside. 31
Vaccination with a synthetic nonapeptide expressed in human tumors prevents colorectal cancer liver metastases in syngeneic rats 31
Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats. 31
Preclinical studies using ONCOFIDä-S, a new SN38-hyaluronic acid bioconjugate, for CD44-targeted therapy of colorectal carcinoma. 30
Early detection of molecular markers suitable for colorectal diagnosis and therapy in carcinogenesis model 30
Lymphonodes micrometastases detection by tumor associated antigens analysis 30
Induction of apoptosis in neoplastic cells by anthracycline antitumor drugs: nuclear and cytoplasmic triggering? 29
Circulating survivin-IGM is a novel candidate biomarker of cirrhosis and increases with child score in patients affected by liver diseases 29
Analysis of Melan-A/MART-1 antigen expression during differentiation induced by Cyanidin-3-O-B glucopyranoside in human melanoma cells 29
Combined treatment with thymosin-alpha1 and low dose interferon-alpha after dacarbazine in advanced melanoma. 29
Thymosin alpha-1 and Cancer: Action on Immune Effector and Tumor Target Cells. 28
Valutazione degli effetti antitumorali e/o antimetastatici in vivo del bioconiugato HIRID in un modello di tumore sperimentale indotto nel ratto da una linea di carcinoma del colon singenica. 28
Totale 4.775
Categoria #
all - tutte 17.588
article - articoli 9.863
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 886
Totale 28.337


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024145 0 0 0 0 0 0 0 0 10 35 41 59
2024/20251.981 72 11 122 91 460 120 28 140 59 128 402 348
2025/20262.498 119 197 239 394 489 119 360 133 139 161 74 74
2026/2027582 158 109 315 0 0 0 0 0 0 0 0 0
Totale 5.206